Biotech entity
All 1 tracked stories fall under one category: pharma. Bank of America Corp DE is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Spyglass Pharma, Inc. appears in 1 tracked Biotech story from August 10, 2026.
Last mentioned: Aug 10, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: pharma. Bank of America Corp DE is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Spyglass Pharma, Inc. appears in 1 tracked Biotech story from August 10, 2026. The tracked stories average 2 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 8 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Spyglass Pharma, Inc.. Shared-story counts are live from our verified record — not editorial picks.
Spyglass Pharma's stock plunges to a new 52-week low of $17.56 despite a consensus 'Moderate Buy' rating and an average analyst target of $45. For biotech investors, the 156% upside potential must be weighed against a recent earnings miss and a downgrade to sell, raising questions about near-term pipeline catalysts.
Source: tickerreport.com · dailypolitical.com
Spyglass Pharma, Inc. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
